CAD (protein)
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | |
---|---|
Identifiers | |
Symbol | CAD |
Entrez | 790 |
HUGO | 1424 |
OMIM | 114010 |
RefSeq | NM_004341 |
UniProt | P27708 |
Other data | |
EC number | 2.1.3.2 |
Locus | Chr. 2 p21 |
CAD protein (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) is a trifunctional multi-domain enzyme involved in the first three steps of pyrimidine biosynthesis. De-novo synthesis starts with cytosolic carbamoylphosphate synthetase II which uses glutamine, carbon dioxide and ATP. This enzyme is inhibited by uridine triphosphate (feedback inhibition).
In 2015, the first observed pathological mutations of CAD were found in a four-year-old boy.[5]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000084774 - Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000013629 - Ensembl, May 2017
- ↑ "Human PubMed Reference:".
- ↑ "Mouse PubMed Reference:".
- ↑ Ng BG, Wolfe LA, Ichikawa M, Markello T, He M, Tifft CJ, Gahl WA, Freeze HH (June 2015). "Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors". Human Molecular Genetics. 24 (11): 3050–7. doi:10.1093/hmg/ddv057. PMC 4424951. PMID 25678555.
External links
- CAD+trifunctional+enzyme at the US National Library of Medicine Medical Subject Headings (MeSH)
- Human CAD genome location and CAD gene details page in the UCSC Genome Browser.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.